[Chronic viral hepatitis due to the hepatitis C virus (HCV): treatment experience with lymphoblast interferon-alpha].
Ten patients affected with HCV-related chronic hepatitis received alpha lymphoblastoid-IFN, 3 mU i.m. TW, for 12 months. We obtained: 4 complete responses, 5 partial responses, 1 non-response (therapy stopped after 3 months). During the fourteen months follow-up, 4 patients (1 complete responder, 3 partial responders) relapsed.
Foti
G
G
Regione Calabria, Azienda Ospedaliera Bianchi-Melacrino-Morelli, Reggio Calabria.
De Cicco
M
M
Masseo
A
A
Mangano
C
C
Tripodi
A
A
Foti
N
N
D000328:Adult; D002908:Chronic Disease; D004341:Drug Evaluation; D005260:Female; D005500:Follow-Up Studies; D006526:Hepatitis C / Q000628:therapy*; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D012074:Remission Induction; D013997:Time Factors
D016898:Interferon-alpha